Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis-Reference-Cited by-同舟云学术

Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis

Published:2006-05 Issue:5 Volume:55 Page:656-661
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Anan Futoshi,Takahashi Naohiko,Shimomura Tsuyoshi,Imagawa Muneharu,Yufu Kunio,Nawata Tomoko,Nakagawa Mikiko,Yonemochi Hidetoshi,Eshima Nobuoki,Saikawa Tetsunori,Yoshimatsu Hironobu

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference39 articles.

1. Elevated risk of stroke among patients with end-stage renal disease;Seliger;Kidney Int,2003

2. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients;Iseki;Kidney Int,1993

3. Predictors of stroke in patients receiving chronic hemodialysis;Iseki;Kidney Int,1996

4. Silent cerebral infarction in hemodialysis patients;Nakatani;Am J Nephrol,2003

5. Silent cerebral infarction predicts vascular events in hemodialysis patients;Naganuma;Kidney Int,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease;Heliyon;2021-02

2. Brain and Kidney Crosstalk;Brain and Kidney Crosstalk;2020

3. Cognitive Dysfunction in Patients with Chronic Kidney Disease;Saudi Journal of Kidney Diseases and Transplantation;2020

4. Folic Acid and Vitamin B12 Administration in CKD, Why Not?;Nutrients;2019-02-13

5. Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise;BioMed Research International;2017